Filed Pursuant to Rule 424(b)(3) Registration No. 333-74724 PROSPECTUS SUPPLEMENT NO. 1 (TO PROSPECTUS DATED MARCH 11, 2002) 1,882,583 SHARES BRADLEY PHARMACEUTICALS, INC. COMMON STOCK This prospectus supplement supplements and amends the prospectus dated March 11, 2002, relating to 1,882,583 shares of common stock of Bradley Pharmaceuticals, Inc. offered by a number of Bradley's stockholders. The two tables in the prospectus under "Selling Stockholders", which set forth the number of shares offered by each of the selling stockholders and information concerning their beneficial ownership of common stock, are hereby amended by deleting Paramount Capital and listing additional selling stockholders in its place, as follows: Beneficial Ownership of Shares Name of Selling of Common Stock Prior to Stockholder Offering - ---------------------------- --------------------------------------- Number (1) Percentage ----------------- ----------------- Lindsay Rosenwald 35,757 * Timothy McInerney 25,000 * Scott A. Katzmann 13,095 * Michael Weiser 7,500 * Jason Stein 5,000 * Mark Rogers 3,451 * David Tanen 1,726 * Stephen Rocamboli 1,726 * Benjamin Bernstein 1,341 * Vincent Aita 1,341 * Michael Mashaal 1,341 * Andrew Daniels 1,000 * Norman Katzwer 920 * Joshua Kazam 135 * Peter Kash 67 * Joan Bottkol 300 * Hannah Vogler 300 * Number of Shares of Beneficial Ownership of Name of Selling Common Stock Shares of Common Stock Stockholder to be Offered (1) After Offering - ------------------------ ------------------------ ---------------------------- Number Percentage ----------- --------------- Lindsay Rosenwald 35,757 - * Timothy McInerney 25,000 - * Scott A. Katzmann 13,095 - * Michael Weiser 7,500 - * Jason Stein 5,000 - * Mark Rogers 3,451 - * David Tanen 1,726 - * Stephen Rocamboli 1,726 - * Benjamin Bernstein 1,341 - * Vincent Aita 1,341 - * Michael Mashaal 1,341 - * Andrew Daniels 1,000 - * Norman Katzwer 920 - * Joshua Kazam 135 - * Peter Kash 67 - * Joan Bottkol 300 - * Hannah Vogler 300 - * ____________________ * Represents beneficial ownership of less than one percent. (1) Consists of shares purchasable upon exercise of warrants with an exercise price of $8.50 per share. Investing in common stock involves risk. Before you invest, you should consider carefully the "Risk Factors" beginning on page 4 of the prospectus. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved these securities or passed upon the accuracy or adequacy of this prospectus supplement or the prospectus. Any representation to the contrary is a criminal offense. The date of this prospectus supplement is December 9, 2002. 2